Hermetica Superfood Encyclopedia
The Short Answer
Leaf extracts of Ravenala madagascariensis contain rutin, isorhamnetin glycosides, and proanthocyanidins that exert antioxidant activity via free-radical scavenging (ABTS up to 438.46 mgTE/g in methanol extract) and inhibit enzymes including acetylcholinesterase and alpha-glucosidase through in silico-confirmed binding. Preclinical data demonstrate bacteriostatic activity against enteric pathogens at 200 mg/mL and larvicidal efficacy causing 100% Culex larval mortality at 200–250 ppm, though no human clinical trials exist to confirm therapeutic benefit.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordRavenala madagascariensis benefits
Traveler's Palm — botanical close-up
Health Benefits
**Antioxidant Activity**
Leaf extracts exhibit potent free-radical scavenging capacity, with aqueous extracts reaching 154.08 ± 2.43 mgTE/g (DPPH) and 249.40 ± 3.01 mgTE/g (FRAP), driven by rutin and isorhamnetin glycosides that donate hydrogen atoms to neutralize reactive oxygen species.
**Enzyme Inhibition (Metabolic Support)**
In silico molecular docking studies indicate that flavonoids and phenolic acids from methanol and ethyl acetate extracts bind favorably to alpha-amylase and alpha-glucosidase active sites, suggesting potential for modulating post-prandial glucose metabolism, though no in vivo or human data confirm this effect.
**Acetylcholinesterase Inhibition**
Methanol leaf extracts demonstrate the strongest in silico binding affinity to acetylcholinesterase among tested fractions, implicating rutin and isorhamnetin glycosides as candidate neuroprotective agents, though this remains entirely preliminary without cell-based or animal validation.
**Antibacterial Properties**
Ethanol and n-hexane leaf extracts exhibit bacteriostatic activity at 200 mg/mL against enteric bacterial pathogens, attributed to the combined action of extracted phenolics, glycosides, and tannins disrupting bacterial membrane integrity.
**Larvicidal Efficacy**
Ethyl acetate fractions achieve 100% mortality of Culex mosquito larvae at 200–250 ppm, with tannins, steroids, alkaloids, and anthraquinones implicated as the active larvicidal constituents, offering a potential botanical alternative for vector control.
**Anti-proliferative Potential**
Methanol extracts show cytotoxicity against HT29 human colorectal adenocarcinoma cells with an IC50 of 506.99 µg/mL, suggesting moderate anti-proliferative activity, though this concentration is high relative to standard oncological agents and requires further mechanistic study.
**Traditional Antipyretic Use**
Ravenala madagascariensis is employed in Malagasy ethnomedicine for fever management, a use plausibly supported by the anti-inflammatory potential of its flavonoid constituents, though controlled evidence for antipyretic efficacy in humans is entirely absent.
Origin & History
Natural habitat
Ravenala madagascariensis is endemic to Madagascar, thriving in the island's tropical rainforests and disturbed forest margins, particularly in the eastern humid zones. Despite its common name 'Traveler's Palm,' it is not a true palm but belongs to the family Strelitziaceae, growing as a distinctive fan-shaped tree reaching up to 10 meters. It is widely cultivated as an ornamental plant across tropical regions worldwide, though its medicinal applications remain rooted in Malagasy traditional practice.
“Ravenala madagascariensis holds deep cultural significance in Madagascar, where it is the national symbol, appearing on the country's emblems and currency, and is revered as a provider of water, food, and shelter by rural communities. In Malagasy ethnomedicine, various plant parts—particularly the leaves—are used in traditional preparations for managing fever, situating it within a broader African and island-Southeast African tradition of botanical antipyretics. The plant's common name, 'Traveler's Palm,' derives from the practice of travelers using the cupped leaf bases as a source of drinking water, reflecting its practical cultural utility beyond strictly medicinal applications. Despite its prominent cultural role, systematic documentation of specific traditional preparation methods, dosing practices, or historical pharmacopeial references in the scientific literature remains sparse, representing a significant gap in ethnobotanical scholarship.”Traditional Medicine
Scientific Research
Published research on Ravenala madagascariensis is confined to a small number of in vitro phytochemical characterization studies and computational docking analyses, with no peer-reviewed clinical trials, randomized controlled trials, or systematic animal pharmacology studies identified in the literature. The most comprehensive phytochemical work used HPLC-ESI-Q-TOF-MS to identify 41 metabolites across methanol, ethyl acetate, and aqueous leaf extracts, with antioxidant and enzyme inhibition assays conducted in cell-free systems only. Antibacterial testing was performed using broth dilution or disc diffusion against a limited panel of enteric organisms, while larvicidal data derive from single laboratory bioassay experiments using Culex quinquefasciatus with no replication across independent research groups. Authors of the primary studies explicitly acknowledge a 'dearth of scientific investigations,' and the overall evidence base is insufficient to support any clinical or therapeutic claims for human use.
Preparation & Dosage
Traditional preparation
**Crude Ethanol/n-Hexane Extract (Antibacterial Research Use)**
25–200 mg/mL used in in vitro bacteriostatic assays; no human dose established
Concentrations of .
**Methanol Leaf Extract (Antioxidant/Enzyme Inhibition Research)**
Applied at concentrations producing 438.46 mgTE/g ABTS capacity; strictly a laboratory reference quantity with no supplement dose equivalent.
**Aqueous (Hot/Cold Water) Extract (Traditional Preparation)**
Cold and hot aqueous infusions of leaves represent the most culturally plausible preparation method for Malagasy traditional fever use; no standardized dose, concentration, or preparation protocol has been formally documented.
**Ethyl Acetate Fraction (Larvicidal Use)**
Effective at 200–250 ppm (0.02–0.025%) in water for 100% Culex larval mortality; intended for environmental vector control, not human consumption.
**Standardization**
No commercial extract standardization exists; no established marker compound percentage for supplement use.
**Important Note**
No safe or effective human supplemental dose has been determined; self-administration is unsupported by evidence and potentially hazardous given cyanogenic glycoside content.
Nutritional Profile
Ravenala madagascariensis leaves are not consumed as a dietary food source, and no conventional macronutrient or micronutrient composition data (protein, fat, carbohydrate, vitamins, minerals) are reported in available scientific literature. Phytochemically, methanol extracts yield 61.06 ± 0.75 mg gallic acid equivalents (GAE)/g total phenolics, 32.26 ± 0.48 mg rutin equivalents (RE)/g total flavonoids, and 16.44 ± 0.47 mg caffeic acid equivalents (CAE)/g phenolic acids, while aqueous extracts contain the highest total phenolics at 64.47 ± 0.19 mg GAE/g. Secondary metabolite screening identifies cyanogenic glycosides (40–49%), anthraquinones (10–20%), terpenes (~10%), sterols (5–10%), flavonoids (12–20%), phlobatannins (0.36%), and cardiac glycosides (0.08%) in leaf material. Bioavailability of these phytochemicals in humans is entirely unstudied; the high cyanogenic glycoside burden represents a potential metabolic hazard if extracts are ingested without appropriate processing.
How It Works
Mechanism of Action
The dominant flavonoids—rutin and isorhamnetin glycosides—exert antioxidant effects through direct hydrogen atom transfer and single-electron transfer to DPPH, ABTS, and superoxide radicals, as well as metal ion chelation that suppresses Fenton-type oxidative reactions, quantified across DPPH, FRAP, ABTS, CUPRAC, and phosphomolybdenum assay platforms. Molecular docking analysis of the 41 HPLC-ESI-Q-TOF-MS-characterized metabolites shows energetically favorable binding to the catalytic gorge of acetylcholinesterase (methanol extract compounds), to the active site of alpha-amylase (ethyl acetate extract, potentially via competitive inhibition of starch hydrolysis), and to alpha-glucosidase (methanol extract), mechanisms analogous to those of known enzyme inhibitors like acarbose. Antibacterial activity against enteric organisms is mechanistically linked to phenolic disruption of bacterial cell membrane permeability and glycoside interference with metabolic processes, operating at bacteriostatic rather than bactericidal concentrations. Larvicidal fractions likely act through anthraquinone- and steroid-mediated interference with larval cuticle integrity and nervous system function, with tannin-protein precipitation contributing to digestive toxicity in Culex larvae.
Clinical Evidence
No clinical trials of any phase have been conducted with Ravenala madagascariensis extracts in human subjects. All available bioactivity data originate from cell-free antioxidant assays, computational molecular docking, in vitro cytotoxicity screening against HT29 cells, and laboratory-scale antibacterial and larvicidal bioassays. The cytotoxic IC50 of 506.99 µg/mL for methanol extract against HT29 cells, while measurable, is substantially higher than concentrations considered potent in oncological research, and no pharmacokinetic, bioavailability, or safety data exist to bridge these in vitro findings to human relevance. Confidence in any therapeutic outcome for this ingredient is therefore very low, and its traditional use for fever in Malagasy medicine has not been subjected to any form of controlled clinical evaluation.
Safety & Interactions
The high cyanogenic glycoside content of leaf extracts (reported at 40–49% of certain extract fractions) represents a serious potential toxicity concern, as cyanogenic glycosides are enzymatically hydrolyzed to hydrogen cyanide upon ingestion, with toxicity well-documented in humans at relatively low cyanide exposures. Cardiac glycosides detected at 0.08% in leaf material may interact with digoxin and other cardiac glycoside medications, as well as antiarrhythmic drugs, by additive or synergistic effects on cardiac sodium-potassium ATPase, necessitating extreme caution in individuals with cardiovascular conditions or those on cardiac medications. Methanol extract cytotoxicity against HT29 cells (IC50 506.99 µg/mL) indicates anti-proliferative potential that could theoretically interact with cytotoxic chemotherapy regimens, though no pharmacological interaction data exist. No human safety thresholds, maximum tolerable doses, pregnancy or lactation guidance, or adverse event profiles have been established; medicinal use in humans cannot be recommended in the absence of formal safety studies.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ravenala madagascariensisTraveler's PalmTraveller's TreeArbre du voyageurRavinala
Frequently Asked Questions
What is Ravenala madagascariensis used for in traditional medicine?
In Malagasy traditional medicine, Ravenala madagascariensis leaves are used primarily for fever management, making it an ethnobotanical antipyretic. However, no clinical trials have confirmed this use, and the specific preparation methods and dosages used by traditional healers have not been formally documented in peer-reviewed literature.
Is Ravenala madagascariensis safe to consume or take as a supplement?
Ravenala madagascariensis leaves contain cyanogenic glycosides at 40–49% of certain extract fractions and cardiac glycosides at 0.08%, both of which pose significant toxicity risks if ingested without appropriate processing. No human safety studies, established safe doses, or regulated supplement forms exist, and consumption cannot be recommended based on current evidence.
What bioactive compounds are found in Ravenala madagascariensis leaves?
HPLC-ESI-Q-TOF-MS analysis identified 41 metabolites in leaf extracts, with rutin as the most abundant compound, alongside isorhamnetin glycosides, epafzelechin monomers and dimers, proanthocyanidins, phenolic acids, terpenes, sterols, anthraquinones, and cyanogenic glycosides. Methanol extracts contain 32.26 ± 0.48 mg rutin equivalents/g total flavonoids and 61.06 ± 0.75 mg GAE/g total phenolics.
Does Ravenala madagascariensis have antibacterial properties?
In vitro laboratory studies found that ethanol and n-hexane leaf extracts exhibit bacteriostatic activity against enteric bacterial pathogens at a concentration of 200 mg/mL, attributed to phenolics, glycosides, and tannins. This effect has not been tested in animal models or human trials, and the high concentrations required make direct translational relevance to human therapy uncertain.
What is the antioxidant capacity of Ravenala madagascariensis leaf extract?
Aqueous leaf extracts demonstrate DPPH radical scavenging of 154.08 ± 2.43 mgTE/g and FRAP values of 249.40 ± 3.01 mgTE/g, while methanol extracts reach the highest ABTS capacity at 438.46 ± 1.69 mgTE/g, driven primarily by rutin, isorhamnetin glycosides, and proanthocyanidins. These are in vitro cell-free measurements and do not reflect bioavailable antioxidant activity in the human body.
What is the difference between aqueous and solvent extracts of Traveler's Palm for antioxidant potency?
Aqueous extracts of Ravenala madagascariensis demonstrate superior antioxidant capacity compared to many solvent-based extracts, with DPPH values reaching 154.08 ± 2.43 mgTE/g and FRAP values of 249.40 ± 3.01 mgTE/g. The water-based extraction method effectively preserves the activity of rutin and isorhamnetin glycosides, the primary flavonoid compounds responsible for free-radical scavenging. This makes aqueous leaf preparations potentially the most bioavailable form for obtaining the herb's antioxidant benefits.
Does Traveler's Palm interact with medications that inhibit metabolic enzymes?
Molecular docking studies suggest that flavonoids in Ravenala madagascariensis may interact with cytochrome P450 enzymes and other metabolic pathways, which could theoretically affect drug metabolism. Individuals taking medications metabolized by CYP3A4, CYP2D6, or other major enzymes should consult a healthcare provider before supplementing with Traveler's Palm extracts. Clinical data on actual drug-supplement interactions remain limited, so caution is warranted in polypharmacy situations.
Who would benefit most from Traveler's Palm supplementation based on its mechanism of action?
Individuals experiencing oxidative stress, inflammatory conditions, or seeking preventative antioxidant support may benefit most from Ravenala madagascariensis supplementation, given its potent free-radical scavenging capacity. Those interested in metabolic support and enzymatic function optimization may also find value in its flavonoid profile, particularly the bioactive rutin and isorhamnetin glycosides. However, people with compromised liver or kidney function, or those on enzyme-inhibiting medications, should seek professional guidance before use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w travelers-palm-ravenala-madagascariensis curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
